UC BON.CAP.CERT. 09/24 EVT/ DE000HD5GL24 /
30/08/2024 21:46:13 | Chg.+0.050 | Bid21:59:04 | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.500EUR | +0.78% | 6.390 Bid Size: 10,000 |
- Ask Size: - |
EVOTEC SE INH O.N. | - - | 27/09/2024 | Call |
GlobeNewswire
11/12/2023
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
07/11/2023
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
15/02/2018
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
08/01/2018
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
14/09/2017
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire
29/11/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
27/10/2011
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire
09/09/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
05/09/2011
Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire
05/09/2011
Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire
18/08/2011
Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire
11/08/2011
Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire
11/08/2011
Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire
07/07/2011
Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases